Extended phenotypic characterization of a novel <scp>Helsmoortel‐van der Aa</scp> syndrome case series
Giulia Pascolini(Istituto Dermopatico dell'Immacolata), Illana Gozes(Tel Aviv University), Biagio Didona(Istituto Dermopatico dell'Immacolata), Giovanni Di Zenzo(Istituto Dermopatico dell'Immacolata), Annarita Panebianco(Istituto Dermopatico dell'Immacolata)
Cited by 7
Related Papers
Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein
|Journal of Biological Chemistry|2001|261
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247
Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model
|Journal of Pharmacology and Experimental Therapeutics|2007|218
Bullous Pemphigoid: Trigger and Predisposing Factors
|Biomolecules|2020|165
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
|Neurobiology of Disease|2009|122